ABSTRACT
Staphylococcus aureus can be a harmless coloniser, but it can also cause severe infections in humans, livestock and wildlife. Regarding the latter, only few studies have been performed and knowledge on virulence factors is insufficient. The aim of the present study was to study S. aureus isolates from deceased wild beavers (Castor fiber). Seventeen isolates from eleven beavers, found in Germany and Austria, were investigated. Antimicrobial and biocide susceptibility tests were performed. Isolates were characterised using S. aureus-specific DNA microarrays, spa typing and whole-genome sequencing. From two isolates, prophages were induced by mitomycin C and studied by transmission electron microscopy. Four isolates belonged to clonal complex (CC) 8, CC12, and CC398. Twelve isolates belonged to CC1956 and one isolate was CC49. The CC49 and CC1956 isolates carried distinct lukF/S genes related to the Panton-Valentine leukocidin (PVL) from human isolates of S. aureus. These genes were located on related, but not identical, Siphovirus prophages. The beavers, from which those isolates originated, suffered from abscesses, purulent organ lesions and necrotising pneumonia, i.e., clinical manifestations resembling symptoms of severe PVL-associated disease in humans. It might thus be assumed that the "Beaver Leukocidin (BVL, lukF/S-BV)"-positive strains are beaver-specific pathogens, and further studies on their clinical role as well as on a possible transmissibility to other species, including humans, are warranted.
Subject(s)
Bacterial Toxins/analysis , Exotoxins/analysis , Leukocidins/analysis , Rodentia/microbiology , Staphylococcal Infections/microbiology , Staphylococcus Phages/isolation & purification , Staphylococcus aureus/isolation & purification , Staphylococcus aureus/virology , Animals , Bacterial Toxins/genetics , Bacterial Typing Techniques , Exotoxins/genetics , Genes, Bacterial , Genes, Viral , Humans , Leukocidins/genetics , Staphylococcal Infections/veterinary , Staphylococcus Phages/genetics , Staphylococcus aureus/geneticsABSTRACT
New virulence factors, such as the Panton-Valentine leukocidin (PVL), are appearing during Staphylococcus aureus infections occurring in the pediatric population. Such factors increase the aggressiveness and risk of dissemination of the bacteria, causing infections to be life-threatening. An early diagnosis is thus especially important. We present a case of osteomyelitis, venous thrombosis, and septic emboli occurring in a pediatric patient that should trigger suspicion of a PVL-positive strain. A multidisciplinary approach is necessary to enable rapid diagnosis and early treatment, which is essential for successful management of these infections. Management is based on broad-spectrum antibiotics, in combination with aggressive surgical treatment and antithrombotic therapy. In patients infected with S. aureus whose condition worsens quickly, PVL gene sequencing should be considered.
Subject(s)
Osteomyelitis/etiology , Venous Thrombosis/etiology , Anti-Bacterial Agents/therapeutic use , Bacterial Toxins/analysis , Bacterial Toxins/blood , Child , Exotoxins/analysis , Exotoxins/blood , Female , Humans , Intensive Care Units, Pediatric/organization & administration , Intensive Care Units, Pediatric/statistics & numerical data , Leukocidins/analysis , Leukocidins/blood , Osteomyelitis/complications , Osteomyelitis/physiopathology , Staphylococcal Infections/diagnosis , Staphylococcus aureus/drug effects , Staphylococcus aureus/pathogenicity , Venous Thrombosis/drug therapy , Venous Thrombosis/physiopathologyABSTRACT
BACKGROUND: Mediastinitis caused by hematogenous spread of an infection is rare. We report the first known case of community-acquired mediastinitis from hematogenous origin in an immunocompetent adult. This rare invasive infection was due to Panton-Valentine Leucocidin-producing (PVL+) methicillin-susceptible Staphylococcus aureus (MSSA). CASE PRESENTATION: A 22-year-old obese man without other medical history was hospitalized for febrile precordial chest pain. He reported a cutaneous back abscess 3 weeks before. CT-scan was consistent with mediastinitis and blood cultures grew for a PVL+ MSSA. Intravenous clindamycin (600 mg t.i.d) and cloxacillin (2 g q.i.d.), secondary changed for fosfomycin (4 g q.i.d.) because of a related toxidermia, was administered. Surgical drainage was performed and confirmed the presence of a mediastinal abscess associated with a fistula between the mediastinum and right pleural space. All local bacteriological samples also grew for PVL+ MSSA. In addition to clindamycin, intravenous fosfomycin was switched to trimethoprim-sulfamethoxazole after 4 weeks for a total of 10 weeks of antibiotics. CONCLUSIONS: We present the first community-acquired mediastinitis of hematogenous origin with PVL+ MSSA. Clinical evolution was favorable after surgical drainage and 10 weeks of antibiotics. The specific virulence of MSSA PVL+ strains played presumably a key role in this rare invasive clinical presentation.
Subject(s)
Bacterial Toxins/analysis , Community-Acquired Infections/diagnosis , Exotoxins/analysis , Immunocompetence , Leukocidins/analysis , Mediastinitis/diagnosis , Mediastinitis/microbiology , Staphylococcal Infections/diagnosis , Staphylococcus aureus/metabolism , Abscess/drug therapy , Abscess/microbiology , Abscess/surgery , Anti-Bacterial Agents/therapeutic use , Anti-Infective Agents, Urinary/therapeutic use , Clindamycin/therapeutic use , Community-Acquired Infections/drug therapy , Drainage , Humans , Male , Mediastinitis/drug therapy , Mediastinitis/immunology , Staphylococcal Infections/drug therapy , Staphylococcal Infections/immunology , Staphylococcal Infections/microbiology , Treatment Outcome , Trimethoprim, Sulfamethoxazole Drug Combination/therapeutic use , Young AdultABSTRACT
BACKGROUND & AIMS: Alcohol-associated liver disease is a leading indication for liver transplantation and a leading cause of mortality. Alterations to the gut microbiota contribute to the pathogenesis of alcohol-associated liver disease. Patients with alcohol-associated liver disease have increased proportions of Candida spp. in the fecal mycobiome, yet little is known about the effect of intestinal Candida on the disease. Herein, we evaluated the contributions of Candida albicans and its exotoxin candidalysin in alcohol-associated liver disease. METHODS: C. albicans and the extent of cell elongation 1 (ECE1) were analyzed in fecal samples from controls, patients with alcohol use disorder and those with alcoholic hepatitis. Mice colonized with different and genetically manipulated C. albicans strains were subjected to the chronic-plus-binge ethanol diet model. Primary hepatocytes were isolated and incubated with candidalysin. RESULTS: The percentages of individuals carrying ECE1 were 0%, 4.76% and 30.77% in non-alcoholic controls, patients with alcohol use disorder and patients with alcoholic hepatitis, respectively. Candidalysin exacerbates ethanol-induced liver disease and is associated with increased mortality in mice. Candidalysin enhances ethanol-induced liver disease independently of the ß-glucan receptor C-type lectin domain family 7 member A (CLEC7A) on bone marrow-derived cells, and candidalysin does not alter gut barrier function. Candidalysin can damage primary hepatocytes in a dose-dependent manner in vitro and is associated with liver disease severity and mortality in patients with alcoholic hepatitis. CONCLUSIONS: Candidalysin is associated with the progression of ethanol-induced liver disease in preclinical models and worse clinical outcomes in patients with alcoholic hepatitis. LAY SUMMARY: Candidalysin is a peptide toxin secreted by the commensal gut fungus Candida albicans. Candidalysin enhances alcohol-associated liver disease independently of the ß-glucan receptor CLEC7A on bone marrow-derived cells in mice without affecting intestinal permeability. Candidalysin is cytotoxic to primary hepatocytes, indicating a direct role of candidalysin on ethanol-induced liver disease. Candidalysin might be an effective target for therapy in patients with alcohol-associated liver disease.
Subject(s)
Candida albicans/metabolism , Exotoxins/metabolism , Fungal Proteins/metabolism , Hepatitis, Alcoholic/metabolism , Hepatitis, Alcoholic/microbiology , Liver Diseases, Alcoholic/metabolism , Liver Diseases, Alcoholic/microbiology , Adult , Aged , Animals , Case-Control Studies , Cells, Cultured , Disease Models, Animal , Exotoxins/analysis , Exotoxins/pharmacology , Feces/microbiology , Female , Fungal Proteins/analysis , Fungal Proteins/pharmacology , Gastrointestinal Microbiome , Hepatitis, Alcoholic/mortality , Hepatocytes/drug effects , Humans , Lectins, C-Type/deficiency , Lectins, C-Type/genetics , Liver Diseases, Alcoholic/mortality , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Middle Aged , Severity of Illness IndexABSTRACT
Exotoxins contribute to the infectious processes of many bacterial pathogens, mainly by causing host tissue damages. The production of exotoxins varies according to the bacterial species. Recent advances in proteomics revealed that pathogenic bacteria are capable of simultaneously producing more than a dozen exotoxins. Interestingly, these toxins may be subject to post-transcriptional modifications in response to environmental conditions. In this review, we give an outline of different bacterial exotoxins and their mechanism of action. We also report how proteomics contributed to immense progress in the study of toxinogenic potential of pathogenic bacteria over the last two decades.
Subject(s)
Exotoxins/analysis , Exotoxins/toxicity , Toxins, Biological/analysis , Toxins, Biological/toxicity , Animals , Humans , ProteomicsABSTRACT
The aim of this study was to describe the clinical features of bone and joint infections (BJI) due to Panton-Valentine Leukocidin producing (PVL+) Staphylococcus aureus (SA) in French Guiana.A multicenter study that consists of a retrospective charts review of children admitted for PVL+ S. aureus BJI between January 2010 and December 2015.Six patients with SA-PVL BJI were identified during the study period: 2 osteomyelitis, 1 septic arthritis, and 3 disseminated BJI. The median age was 11 years old (4-14 years), and fever lasted for 3.2 days (2-5 days) before diagnosis. An open skin wound preceded the BJI in 5/6 patients. One patient presented with a septic thrombophlebitis of the femoral-popliteal vein on admission. Methicillin-susceptible Staphylococcus aureus (MSSA) were identified for all patients. Three patients had complications: 2 cases of necrotizing pneumonia and 2 pericarditis, with 1 death caused by cardiac tamponade.SA-PVL BJI was not frequent. Strains were susceptible to methicillin, but responsible of severe BJI. Early diagnosis and a multidisciplinary management of these infections are essential to prevent further complications.
Subject(s)
Arthritis, Infectious/microbiology , Bacterial Toxins/analysis , Exotoxins/analysis , Leukocidins/analysis , Osteomyelitis/microbiology , Staphylococcal Infections/microbiology , Adolescent , Anti-Bacterial Agents/therapeutic use , Arthritis, Infectious/therapy , C-Reactive Protein/analysis , Child , Child, Preschool , French Guiana , Humans , Methicillin-Resistant Staphylococcus aureus/isolation & purification , Osteomyelitis/therapy , Retrospective Studies , Staphylococcal Infections/therapyABSTRACT
PURPOSE: Potent extracellular toxins including alpha-haemolysin, Panton-Valentine leukocidin (PVL) and toxic-shock syndrome toxin 1 (TSST-1) significantly contribute to Staphylococcus aureus pathogenesis, thus, toxin suppression is a primary focus in treatment of staphylococcal disease. S. aureus maintains complex strategies to regulate toxin expression and previous data have demonstrated that subinhibitory concentrations of beta-lactam antibiotics can adversely increase S. aureus exotoxin production. The current study evaluates the effects of subinhibitory concentrations of tedizolid, a second-generation oxazolidinone derivative, on expression of staphylococcal exotoxins in both methicillin-resistant and methicillin-sensitive S. aureus. METHODOLOGY: S. aureus exotoxin expression levels were compared at 12 and 24 h following treatment with tedizolid, linezolid, nafcillin or vehicle control. RESULTS: Our findings show that the level of antibiotic required to alter toxin production was strain-dependent and corresponds with the quantity of toxin produced, but both tedizolid and linezolid could effectively reduce expression of alpha-haemolysin, PVL and TSST-1 toxin at subinhibitory concentrations. In contrast, nafcillin showed less attenuation and, in some S. aureus strains, led to an increase in toxin expression. Tedizolid consistently inhibited toxin production at a lower overall drug concentration than comparator agents. CONCLUSION: Together, our data support that tedizolid has the potential to improve outcomes of infection due to its superior ability to inhibit S. aureus growth and attenuate exotoxin production.
Subject(s)
Anti-Bacterial Agents/pharmacology , Bacterial Toxins/biosynthesis , Methicillin/pharmacology , Oxazolidinones/pharmacology , Staphylococcus aureus/drug effects , Tetrazoles/pharmacology , Animals , Anti-Bacterial Agents/administration & dosage , Bacterial Toxins/analysis , Bacterial Toxins/antagonists & inhibitors , Dose-Response Relationship, Drug , Enterotoxins/analysis , Enterotoxins/antagonists & inhibitors , Enterotoxins/biosynthesis , Erythrocytes/drug effects , Erythrocytes/metabolism , Exotoxins/analysis , Exotoxins/antagonists & inhibitors , Exotoxins/biosynthesis , Hemolysin Proteins/analysis , Hemolysin Proteins/antagonists & inhibitors , Hemolysin Proteins/biosynthesis , Humans , Leukocidins/analysis , Leukocidins/antagonists & inhibitors , Leukocidins/biosynthesis , Linezolid/administration & dosage , Linezolid/pharmacology , Methicillin Resistance , Methicillin-Resistant Staphylococcus aureus/drug effects , Methicillin-Resistant Staphylococcus aureus/growth & development , Methicillin-Resistant Staphylococcus aureus/metabolism , Microbial Sensitivity Tests , Nafcillin/administration & dosage , Nafcillin/pharmacology , Oxazolidinones/administration & dosage , Rabbits , Sheep , Staphylococcus aureus/growth & development , Staphylococcus aureus/metabolism , Superantigens/analysis , Superantigens/biosynthesis , Tetrazoles/administration & dosageABSTRACT
Staphylococcus aureus is one of the most clinically important bacteria causing infection in humans. It is an important pathogen in surgical site infections (SSIs), especially after orthopedic surgery. Pantone-valentine leukocidin (PVL) has a great importance in the virulence of S.aureus because it can destroy polymorphonuclear cells by necrosis or apoptosis. The spread of PVL positive S.aureus is a great concern, since it may become an important factor for increased morbidity and mortality in SSIs, especially after surgery. In this study, we aimed to investigate the presence of PVL in S.aureus strains isolated from patients who had surgical site infections after orthopedic surgery, and also the clinical status of these patients. Between 2013 and 2017, 101 patients who had SSIs due to S.aureus after orthopedic surgery were included in the study. Identification of the strains was determined by conventional methods and "Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry" (MALDI-TOF MS). Methicillin resistance was determined by Kirby-Bauer disc diffusion method and automated system (Vitek 2, bioMérieux, France). The PVL gene region was investigated by polymerase chain reaction (PCR) method by using the primers Luk-PV-1 and Luk-PV-2. The duration of the patients' hospitalization, C-reactive protein (CRP) and sedimentation levels and clinical status were obtained from the hospital information system, retrospectively. Fifteen (14.9%) of the isolates were methicillin resistance S.aureus (MRSA) and 86 (85.1%) were methicillin susceptibility S.aureus (MSSA). PVL positivity was detected in 14 (13.9%) isolates (3 MRSA, 11 MSSA). The mean hospital stays in PVL-negative patients were 17 (5-73) days and 46 (21-103) days in PVL-positive patients. It was observed that the serologic markers CRP and sedimentation were between 5-7 and 40-60 in PVL negative patients, and between 11-20 and 90-110 in PVL positive patients, respectively. In PVL-negative patients, serologic markers improved in 7-10 days, while in PVL-positive patients they were improved in 17-32 days. Osteomyelitis occurred in six patients (2 PVL positive MRSA, 1 PVL positive MSSA and 3 PVL negative MRSA). In two of the patients who have developed osteomyelitis with PVL-positive MRSA, PVL gene positive S.aureus isolates were observed in their orthopedic SSIs. We also determined that these isolates increased the hospitalization days, improvement time of serological markers and mortality. It is worrisome to isolate PVL-positive S.aureus strains in SSIs. Therefore, we believe that it would be useful to take infection control measures to prevent the spread of these strains in the hospital setting.
Subject(s)
Bacterial Toxins , Exotoxins , Leukocidins , Staphylococcal Infections , Staphylococcus aureus , Surgical Wound Infection/microbiology , Bacterial Toxins/analysis , Bacterial Toxins/genetics , Exotoxins/analysis , Exotoxins/genetics , Humans , Leukocidins/analysis , Leukocidins/genetics , Methicillin-Resistant Staphylococcus aureus/chemistry , Orthopedics , Retrospective Studies , Staphylococcal Infections/microbiology , Staphylococcus aureus/chemistryABSTRACT
Background: Hypochlorous acid (HOCl) demonstrates rapid and broad antimicrobial activity against planktonic and biofilm phenotype bacteria in vitro. Objectives: To identify the protein content present in breast pockets in vivo and calculate the estimated active concentration of HOCl, (PhaseOne, Integrated Healing Technologies, Franklin, TN) following HOCl-protein interactions. Methods: Fluid samples were collected prior to implant insertion in 18 consecutive patients, representing 36 pocket samples, with all cases being bilateral primary breast augmentations. Samples were evaluated by an independent CLIA approved laboratory for albumin and total protein concentration in g/dL. Results were compared to HOCl solution concentration and protein binding potential to determine availability of free HOCl. Results: The mean tissue sample concentration (right and left breast) was 31.6 mg/dL which translates to 0.0001 mmol per 20 cc of interstitial fluid. Mean total protein levels (right and left breast) were 62.3 mg/dL or 0.000187 mmol per 20 cc interstitial fluid. Based upon potential stoichiometric neutralization of HOCl by proteins in either a 1:1 or 3:1 ratio, using 115 cc of HOCl solution (per breast) at a concentration of 250 ppm/mL or 0.025% HOCl or = 0.48 mmol HOCl/dL, there would be 2950 times the amount of active HOCl at a 1:1 reaction ratio, or 983 times more HOCl assuming a 3:1 reaction ratio. Based on the range of identified levels of protein in individual surgical pockets in the study, there is an estimated 242 to 12,500 times more HOCl molecules than protein at a 3:1 molar ratio of binding or reactive protein. Conclusions: n estimated range of 983-2950 times more HOCl molecules are present during irrigation with 230 cc of PhaseOne® (115 cc for each breast) than available protein. This supports the antimicrobial and anti-biofilm activity as described in previous in vitro studies when using PhaseOne® as part of pocket irrigation.
Subject(s)
Anti-Infective Agents/administration & dosage , Bacteria/drug effects , Breast Implantation/adverse effects , Hypochlorous Acid/administration & dosage , Surgical Wound Infection/prevention & control , Adult , Albumins/analysis , Bacteria/metabolism , Biofilms/drug effects , Breast/microbiology , Breast/surgery , Breast Implantation/methods , Endotoxins/analysis , Endotoxins/metabolism , Exotoxins/analysis , Exotoxins/metabolism , Female , Humans , Intraoperative Care/methods , Middle Aged , Proteomics , Surgical Wound Infection/microbiologyABSTRACT
Colorimetric DNA detection is preferred over other methods for clinical molecular diagnosis because it does not require expensive equipment. In the present study, the colorimetric method based on gold nanoparticles (GNPs) and endonuclease enzyme was used for the detection of P. aeruginosa ETA gene. Firstly, the primers and probe for P. aeruginosa exotoxin A (ETA) gene were designed and checked for specificity by the PCR method. Then, GNPs were synthesized using the citrate reduction method and conjugated with the prepared probe to develop the new nano-biosensor. Next, the extracted target DNA of the bacteria was added to GNP-probe complex to check its efficacy for P. aeruginosa ETA gene diagnosis. A decrease in absorbance was seen when GNP-probe-target DNA cleaved into the small fragments of BamHI endonuclease due to the weakened electrostatic interaction between GNPs and the shortened DNA. The right shift of the absorbance peak from 530 to 562nm occurred after adding the endonuclease. It was measured using a UV-VIS absorption spectroscopy that indicates the existence of the P. aeruginosa ETA gene. Sensitivity was determined in the presence of different concentrations of target DNA of P. aeruginosa. The results obtained from the optimized conditions showed that the absorbance value has linear correlation with concentration of target DNA (R: 0.9850) in the range of 10-50ngmL-1 with the limit detection of 9.899ngmL-1. Thus, the specificity of the new method for detection of P. aeruginosa was established in comparison with other bacteria. Additionally, the designed assay was quantitatively applied to detect the P. aeruginosa ETA gene from 103 to 108CFUmL-1 in real samples with a detection limit of 320CFUmL-1.
Subject(s)
ADP Ribose Transferases/genetics , Bacterial Toxins/genetics , Burns/microbiology , DNA Probes/chemistry , DNA, Bacterial/genetics , Endonucleases/metabolism , Exotoxins/genetics , Gold/chemistry , Metal Nanoparticles/chemistry , Pseudomonas aeruginosa/genetics , Virulence Factors/genetics , ADP Ribose Transferases/analysis , Bacterial Toxins/analysis , Biosensing Techniques/methods , Calorimetry/methods , DNA, Bacterial/analysis , Exotoxins/analysis , Humans , Pseudomonas Infections/diagnosis , Pseudomonas Infections/microbiology , Spectrophotometry/methods , Virulence Factors/analysis , Pseudomonas aeruginosa Exotoxin AABSTRACT
Mastitis, a major veterinary problem widespread in many regions, is caused mainly by Staphylococcus spp. However, there is no current reliable information about the role of Staphylococcus aureus and their toxins in the development of mastitis in cows in the territory of the Russian Federation. The aim of this investigation was to determine the profile of exotoxins of S. aureus from cow milk from farms of Central Russia. A total of 60 isolates of S. aureus were obtained from milk samples of cows with the subclinical form of mastitis. The exotoxin genes were identified using 2 types of PCR assays. The diversity of enterotoxin genes was studied by multiplex PCR. The percentage occurrence of enterotoxin genes was as follows: sea, 53.3%; seb, 3.3%; sec, 50%; sed, 4%; see, 46.6%; seg, 70%; sei, 10%; selp, 3.3%; and tsst1, 1.6%. The seh gene was not detected. The genes of pore-forming toxins and phenol-soluble modulins were identified by singleplex PCR and consisted of the following: hlA, 70%; lucS, 46.6%; psmA, 81.6%; psmB, 95%; and hld, 78.3%. The most abundant genes were psm (psmB, 95%), which codes for pore-forming toxins, and seg (70%), which codes for enterotoxins. The production of some enterotoxins in bacterial culture medium was detected by ELISA. The level of toxin production was near 1 ng/mL for SEA, SEE, SEG, SEI, SELP, and TSST-1 and reached a maximal level of 18 ng/mL for SEE. In the present work, we show that subclinical mastitis in cows is associated with S. aureus in the central region of the Russian Federation. Most of the isolates containing enterotoxin genes also had cytotoxin genes.
Subject(s)
Exotoxins/metabolism , Mastitis, Bovine/microbiology , Milk/microbiology , Staphylococcal Infections/veterinary , Staphylococcus aureus/isolation & purification , Animals , Cattle , Exotoxins/analysis , Female , Polymerase Chain Reaction/veterinary , Russia , Staphylococcal Infections/microbiology , Staphylococcus aureus/classification , Staphylococcus aureus/genetics , Staphylococcus aureus/metabolismABSTRACT
Early detection of pathogens or their virulence factors in complex media has a key role in early diagnosis and treatment of many diseases. Nanomolar and selective detection of Exotoxin A, which is a virulence factor secreted from Pseudomonas aeruginosa in the sputum of Cystic Fibrosis (CF) patients, can pave the way for early diagnosis of P. aeruginosa infections. In this study, we conducted a preliminary study to demonstrate the feasibility of optical biodetection of P. aeruginosa Exotoxin A in a diluted artificial sputum mimicking the CF respiratory environment. Our surface engineering approach provides an effective biointerface enabling highly selective detection of the Exotoxin A molecules in the complex media using monoclonal anti-Exotoxin A functionalized microtoroids. The highly resilient microtoroid surface toward other constituents of the sputum provides Exotoxin A detection ability in the complex media by reproducible measurements. In this study, the limit-of-detection of Exotoxin A in the complex media is calculated as 2.45 nM.
Subject(s)
ADP Ribose Transferases/analysis , Bacterial Toxins/analysis , Biosensing Techniques/instrumentation , Biosensing Techniques/methods , Cystic Fibrosis/microbiology , Exotoxins/analysis , Pseudomonas Infections/microbiology , Pseudomonas aeruginosa/pathogenicity , Virulence Factors/analysis , Humans , Limit of Detection , Models, Theoretical , Sputum/microbiology , Surface Properties , Pseudomonas aeruginosa Exotoxin AABSTRACT
From 2011, Hong Kong and mainland China have witnessed a sharp increase in reported cases, with subsequent reports of epidemic scarlet fever in North Asia and the United Kingdom. Here we examine epidemiological data and investigate the genomic context of the predominantly serotype M12 Streptococcus pyogenes scarlet fever isolates from mainland China. Incident case data was obtained from the Chinese Nationwide Notifiable Infectious Diseases Reporting Information System. The relative risk of scarlet fever in recent outbreak years 2011-2016 was calculated using the median age-standardised incidence rate, compared to years 2003-2010 prior this outbreak. Whole genome sequencing was performed on 32 emm12 scarlet fever isolates and 13 emm12 non-scarlet fever isolates collected from different geographic regions of China, and compared with 203 published emm12 S. pyogenes genomes predominantly from scarlet fever outbreaks in Hong Kong (n=134) and the United Kingdom (n=63). We found during the outbreak period (2011-2016), the median age-standardised incidence in China was 4.14/100,000 (95% confidence interval (CI) 4.11-4.18), 2.62-fold higher (95% CI 2.57-2.66) than that of 1.58/100,000 (95% CI 1.56-1.61) during the baseline period prior to the outbreak (2003-2010). Highest incidence was reported for children 5years of age (80.5/100,000). Streptococcal toxin encoding prophage φHKU.vir and φHKU.ssa in addition to the macrolide and tetracycline resistant ICE-emm12 and ICE-HKU397 elements were found amongst mainland China multi-clonal emm12 isolates suggesting a role in selection and expansion of scarlet fever lineages in China. Global dissemination of toxin encoded prophage has played a role in the expansion of scarlet fever emm12 clones. These findings emphasize the role of comprehensive surveillance approaches for monitoring of epidemic human disease.
Subject(s)
Scarlet Fever/epidemiology , Scarlet Fever/microbiology , Serogroup , Streptococcus pyogenes/classification , Adolescent , Adult , Aged , Child , Child, Preschool , China/epidemiology , DNA Transposable Elements/genetics , Demography , Drug Resistance, Bacterial/genetics , Epidemics , Exotoxins/analysis , Female , Genetics, Population , Geography , Humans , Incidence , Infant , Infant, Newborn , Likelihood Functions , Male , Middle Aged , Phylogeny , Seasons , Streptococcus pyogenes/isolation & purification , Young AdultABSTRACT
OBJECTIVES: Community-acquired (CA) methicillin-resistant Staphylococcus aureus (MRSA) isolates belonging to clonal complex 80 (CC80) are recognized as the European CA-MRSA. The prevailing European CA-MRSA clone carries a type IVc staphylococcal cassette chromosome mec (SCCmec) and expresses Panton-Valentine leukocidin (PVL). Recently, a significant increase of PVL-negative CC80 MRSA has been observed in Denmark. The aim of this study was to examine their genetics and epidemiology, and to compare them to the European CA-MRSA clone in order to understand the emergence of PVL-negative CC80 MRSA. METHODS: Phylogenetic analysis of the CC80 S. aureus lineage was conducted from whole-genome sequences of 217 isolates (23 methicillin-susceptible S. aureus and 194 MRSA) from 22 countries. All isolates were further genetically characterized in regard to resistance determinants and PVL carriage, and epidemiologic data were obtained for selected isolates. RESULTS: Phylogenetic analysis revealed the existence of three distinct clades of the CC80 lineage: (a) an methicillin-susceptible S. aureus clade encompassing Sub-Saharan African isolates (n = 13); (b) a derived clade encompassing the European CA-MRSA SCCmec-IVc clone (n = 185); and (c) a novel and genetically distinct clade encompassing MRSA SCCmec-IVa isolates (n = 19). All isolates in the novel clade were PVL negative, but carried remnant parts (8-12 kb) of the PVL-encoding prophage ΦSa2 and were susceptible to fusidic acid and kanamycin/amikacin. Geospatial mapping could link these isolates to regions in the Middle East, Asia and South Pacific. CONCLUSIONS: This study reports the emergence of a novel CC80 CA-MRSA sublineage, showing that the CC80 lineage is more diverse than previously assumed.
Subject(s)
Community-Acquired Infections/epidemiology , Community-Acquired Infections/microbiology , Genotype , Methicillin-Resistant Staphylococcus aureus/classification , Methicillin-Resistant Staphylococcus aureus/genetics , Staphylococcal Infections/epidemiology , Staphylococcal Infections/microbiology , Adolescent , Adult , Africa South of the Sahara/epidemiology , Aged , Aged, 80 and over , Bacterial Toxins/analysis , Europe/epidemiology , Evolution, Molecular , Exotoxins/analysis , Female , Genes, Bacterial , Humans , Leukocidins/analysis , Male , Methicillin-Resistant Staphylococcus aureus/isolation & purification , Microbial Sensitivity Tests , Middle Aged , Molecular Epidemiology , Phylogeny , Prophages/genetics , Whole Genome SequencingABSTRACT
Panton-Valentine Leukocidin (PVL) producing Staphylococcus aureus has been associated with severity of skin infections and pathology that suggest a major role in pathogenicity. The present study aimed to determine the overall prevalence of PVL harbouring S. aureus isolates from cutaneous infections in Iran. A systematic search was performed by using Medline electronic databases (PubMed) from the papers published by Iranian authors to the end of March 2017. Ten publications which met our inclusion criteria were then selected for data extraction and analysis by Comprehensive Meta-Analysis Software. The pooled prevalence of PVL in cutaneous infections was estimated at 27.9% (95% CI: 17.9-40.6). The range of PVL positivity among S. aureus isolates obtained from cutaneous infections was from 7.4% to 55.6%. In summary, despite the emergence of multiple-drug resistant strains, it seems that the overall prevalence of PVL carrying S. aureus in Iran remains steady regardless of methicillin resistance. However, further research is required to elucidate the interplay between the risk of invasive disease and PVL, especially in Iran.
Subject(s)
Bacterial Toxins/analysis , Exotoxins/analysis , Leukocidins/analysis , Staphylococcal Skin Infections/microbiology , Staphylococcus aureus/isolation & purification , Burns/complications , Humans , Incidence , Iran/epidemiology , Methicillin-Resistant Staphylococcus aureus/chemistry , Methicillin-Resistant Staphylococcus aureus/isolation & purification , Staphylococcal Skin Infections/epidemiology , Staphylococcus aureus/chemistry , Wound Infection/epidemiology , Wound Infection/microbiologyABSTRACT
BACKGROUND: Polymorphic toxins (PTs) are multi-domain bacterial exotoxins belonging to distinct families that share common features in terms of domain organization. PTs are found in all major bacterial clades, including many toxic effectors of type V and type VI secretion systems. PTs modulate the dynamics of microbial communities by killing or inhibiting the growth of bacterial competitors lacking protective immunity proteins. RESULTS: In this work, we identified a novel widespread family of PTs, named MuF toxins, which were exclusively encoded within temperate phages and their prophages. By analyzing the predicted proteomes of 1845 bacteriophages and 2464 bacterial genomes, we found that MuF-containing proteins were frequently part of the DNA packaging module of tailed phages. Interestingly, MuF toxins were abundant in the human gut microbiome. CONCLUSIONS: Our results uncovered the presence of the MuF toxin family in the temperate phages of Firmicutes. The MuF toxin family is likely to play an important role in the ecology of the human microbiota where pathogens and commensal species belonging to the Firmicutes are abundant. We propose that MuF toxins could be delivered by phages into host bacteria and either influence the lysogeny decision or serve as bacterial weapons by inhibiting the growth of competing bacteria.
Subject(s)
Bacteria/genetics , Bacterial Toxins/analysis , Bacteriophages/metabolism , Exotoxins/analysis , Genome, Bacterial , Bacteria/virology , Gastrointestinal Microbiome , Humans , Prophages/metabolismSubject(s)
Anti-Bacterial Agents/therapeutic use , Bacteremia/drug therapy , Linezolid/therapeutic use , Methicillin-Resistant Staphylococcus aureus/drug effects , Shock, Septic/drug therapy , Staphylococcal Infections/drug therapy , Anti-Bacterial Agents/administration & dosage , Anti-Bacterial Agents/blood , Bacteremia/microbiology , Bacterial Toxins/analysis , Community-Acquired Infections/drug therapy , Community-Acquired Infections/microbiology , Dose-Response Relationship, Drug , Drug Substitution , Exotoxins/analysis , Humans , Infusions, Intravenous , Leukocidins/analysis , Linezolid/administration & dosage , Linezolid/blood , Male , Methicillin-Resistant Staphylococcus aureus/chemistry , Methicillin-Resistant Staphylococcus aureus/isolation & purification , Middle Aged , Pneumonia, Staphylococcal/drug therapy , Pneumonia, Staphylococcal/microbiology , Shock, Septic/etiology , Shock, Septic/microbiology , Staphylococcal Infections/complications , Staphylococcal Infections/microbiologySubject(s)
Bacterial Toxins/analysis , Exotoxins/analysis , Furunculosis/diagnosis , Leukocidins/analysis , Staphylococcal Infections/diagnosis , Staphylococcus aureus/chemistry , Angola/ethnology , Biopsy , Furunculosis/ethnology , Furunculosis/microbiology , Humans , Male , Middle Aged , Portugal/epidemiology , Recurrence , Skin/microbiology , Skin/pathology , Staphylococcal Infections/ethnology , Staphylococcal Infections/microbiology , Staphylococcus aureus/isolation & purification , TravelABSTRACT
Background: Mannheimia haemolytica is the primary bacterial pathogen in causing bovine respiratory disease with tremendous annual losses in the cattle industry. The leukotoxin from M. haemolytica is the predominant virulence factor. Several leukotoxin activity assays are available but not standardized regarding sample preparation and cell line. Furthermore, these assays suffer from a high standard error, a prolonged time consumption and often complex sample pretreatments, which is important from the bioprocess engineering point of view. Results: Within this study, an activity assay based on the continuous cell line BL3.1 combined with a commercial available adenosine triphosphate viability assay kit was established. The leukotoxin activity was found to be strongly dependent on the sample preparation. Furthermore, the interfering effect of lipopolysaccharides in the sample could be successfully suppressed by adding polymyxin B. We reached a maximum relative P95 value of 14%, which is more than seven times lower compared to current available assays as well as a time reduction up to 88%. Conclusion: Ultimately, the established leukotoxin activity assay is simple, fast and has a high reproducibility. Critical parameters regarding the sample preparation were characterized and optimized making complex sample purification superfluous.
Subject(s)
Animals , Bovine Respiratory Disease Complex/microbiology , Exotoxins/analysis , Mannheimia haemolytica/pathogenicity , Microbiological Techniques , Adenosine Triphosphate , Lipopolysaccharides , Polymyxin BABSTRACT
Leukotoxin M/F'-PV (LukM/F'-PV) produced by bovine mastitis causing Staphylococcus aureus structurally comprises three domains, the ß-sandwich, rim and stem domain. The rim and stem domains interacting with target cell membrane lipid rafts contributes to the virulent trait of the toxin. In the present study, two facts were hypothesized that neutralization of these domains will ebb LukM/F'-PV leukotoxicity. Secondly, the neutralizing antibodies can improve the leukotoxin detection sensitivity in bovine mastitis milk samples. The in silico mapping of S. aureus LukM C-termini comprising these domains predicted seven linear B-cell antigenic epitopes. The immune response of C-terminal truncated recombinant peptides rCtM19 (19 kDa; near carboxy-terminal) having four epitopes and rCtM15 (15 kDa; C-terminal) with three epitopes were evaluated for their diagnostic and neutralization potential. Anti-rCtM19 and anti-rCtM15 antibodies with enhanced immunogenicity had the most striking outcome in IgG-ELISA for detecting native determinants of leukotoxin. For the obtained ELISA values, ROC curve inferred a cut-off score of >0.102 OD405. The assay sensitivity in the range of 90-96% along with 100% specificity and AUC of 0.93-0.98 categorized subclinical and clinical from healthy bovine milk samples. As observed through in vitro neutralization and LDH assays, C-terminus specific antibodies (1:42 titer) deactivating leukotoxicity abolished LukM from interacting with lipid bilayer and LukF for forming pores on bovine neutrophil membrane. As a proof of concept, it was proved that peptide antibodies can be a more specific serodiagnostic and passive therapeutic molecules.